One of the most talked about laboratories at the Technion Institute of Technology is the Laboratory for Nanomaterial-Based Devices (LNBD). The current research of the LNBD team harnesses nanotechnology and medicine to develop and test a tailor-made, non-invasive array of nanosensors for the detection of volatile biomarkers that will indicate an increased risk of disease (e.g., lung cancer, breast cancer, colorectal cancer, prostate cancer, Kidney Disease, Parkinson, Alzheimer, Multiple Sclerosis,etc.) and assist clinicians in determining the proper treatment. To do this, they developed a tool that is based on an artificial (electronic) nose, the Nano Artificial NOSE concept ‘NA-NOSE’, which makes use of cross-selective and sensitive sensor arrays that are trained in their ensemble to detect disease biomarkers. This ‘NA-NOSE’ is used to screen and identify high risk groups for specific disease, and monitor the therapy provided to people affected by that disease to establish point-of-care diagnostics and less invasive treatments.